Skip to main content

Coronavirus vaccine will be 'as safe as it can be' but scientist will admit there is no 100% guarantee in honesty-first fight against anti-vaxxers

The coronavirus vaccine will be 'as safe as it can be' but scientists will admit there is no 100 per cent guarantee in an honesty-first fight against anti-vaxxers. 

As Pfizer and Oxford University enter into their final stages of testing with data suggesting a jab could be deployed 'within weeks', the Department of Health and the Cabinet Office have created a team of civil servants to publicise the vaccine.

Once it has been authorised, the task force will advertise the jab via social media and television. 

But it will acknowledge that the vaccine is not flawless, in order to prevent people becoming disillusioned with the jab if it does not immediately bring an end to the pandemic.

It follows revelations that GPs could offer a coronavirus vaccine on Christmas Day and Boxing Day in a rapid roll-out plan to protect the NHS. 

A Covid-19 vaccine campaign 'will admit the jab is not 100 per cent safe' to ensure people are not swayed by antivax propaganda (pictured: demonstrators in Leicester Square last month)

A Covid-19 vaccine campaign 'will admit the jab is not 100 per cent safe' to ensure people are not swayed by antivax propaganda (pictured: demonstrators in Leicester Square last month)

It normally takes years for vaccines to be green-lit by the UK's drugs watchdog, the Medicines and Healthcare products Regulatory Agency , and a similar body in the EU. 

Regulators must pore over data to make sure jabs will be safe and effective to dish out to millions of people. 

A source told The Times: 'We need to be honest — no clinician would ever say that any vaccine is 100 per cent safe. 

'The truth is that these vaccines are very good and as safe as they can be.'

The source also said that people over the age of 80, who are more at risk from Covid symptoms, will be encouraged to get the jab while those in their 20s with no underlying health conditions may be told that getting the vaccine is not worthwhile.

Heidi Larson, the vaccine confidence project's director at the London School of Hygiene and Tropical Medicine, said that confidence needs to be built with the public first.

The Department of Health and the Cabinet Office have created a team of civil servants to publicise the vaccine through TV and social media (pictured: Health Secretary Matt Hancock)

The Department of Health and the Cabinet Office have created a team of civil servants to publicise the vaccine through TV and social media (pictured: Health Secretary Matt Hancock)

She added: 'Don’t assume people are going to line up for this vaccine, you need to work on it.'

Kate Bingham, chairwoman of the government's vaccine task force, said earlier this week that the inoculations had the 'possibility of being ready before the end of the year.'

But she warned that only four million doses of the Oxford vaccine would be manufactured by Christmas - with ten million doses of the Pfizer vaccine potentially being available by January.

The estimate, which falls short of the Government's suggestion in May that 30 million doses could be supplied by September, would mean that mass deployment among NHS workers and the elderly would not yet be achievable. 

Promotion will acknowledge that the jab is not flawless, to prevent people becoming disillusioned with the jab if it does not immediately bring an end to the pandemic (file photo)

Promotion will acknowledge that the jab is not flawless, to prevent people becoming disillusioned with the jab if it does not immediately bring an end to the pandemic (file photo)

Ms Bingham, the UK's vaccine tsar, has arranged to buy six different vaccines, amounting to more than 350million doses, but there is no guarantee that any will work. 

They will all also have to be submitted for approval by the Medicines and Healthcare products Regulatory Agency but it is not yet known how long this will take.

Professor Andrew Pollard, from Oxford university, agreed that there was 'a small chance' its vaccine would be ready before Christmas.

He said: 'The first step is to reach the point where we can do an analysis and find out whether or not the vaccine works.

'I'm optimistic that we could reach that point before the end of this year.'

WHAT PROGRESS IS BEING MADE WITH COVID-19 VACCINES?

Covid-19 vaccines could be rolled out in the UK within the first half of next year, with the NHS to prepare itself to deliver doses by Christmas 'if they become available'.

After successful trials, vaccines could be rolled out at GP surgeries, pharmacies and mass testing centres.

But health chiefs say a mass vaccination programme is unlikely to get under way before next year.

There are currently more than 200 coronavirus vaccine candidates being tested around the world.

Here is everything you need to know about the race to get a Covid-19 vaccine.

What progress is being made with Covid-19 vaccines?

A total of 44 of the vaccine candidates in development are at clinical trial stage.

Of these, nine are in the phase three stage of clinical evaluation and are being given to thousands of people to confirm safety and effectiveness.

There are two frontrunners in the Covid-19 vaccine race – one from German biotech firm BioNtech and US pharmaceutical company Pfizer, and another being developed by the University of Oxford and AstraZeneca.

Both vaccines are currently in phase three clinical trials.

The Oxford vaccine, called ChAdOx1 nCoV-19, uses a weakened version of a common cold virus which causes infections in chimpanzees.

Other potential vaccines in phase three trials include ones by US drugs firm Moderna and biotech company Novavax.

What trials are ongoing in the UK?

Aside from the Oxford vaccine, a coronavirus jab is being developed by Imperial College London.

The Imperial vaccine is in phase one of clinical testing, where doses are being given to a small group of people to determine whether it is safe and to learn more about the immune response it provokes.

Pharmaceutical companies Sanofi and GlaxoSmithKline have also teamed up with the hope of making a Covid-19 vaccine available by the middle of next year.

The Sanofi/GSK candidate is in the phase two stage, where the vaccine is being given to hundreds of people so scientists can learn more about its safety and correct dosage.

They plan to begin phase three trial by the end of the year.

When will the results from these trials be available?

The head of the UK's vaccines taskforce, Kate Bingham, said data from the vaccine trials at the University of Oxford and AstraZeneca, and Pfizer with BioNTech, could be available this year.

She said if she puts on 'rose-tinted specs' she would hope to see positive interim data from both Oxford and Pfizer BioNtech in early December.

Professor Andrew Pollard, head of Oxford's vaccine trial team, said he is optimistic data on safety and efficacy of their vaccine will be available by the end of the year.

Professor Robin Shattock, who is leading Imperial College London's Covid-19 vaccine effort, said data on its efficacy will be available in the middle of next year.

Does the UK have access to any of these potential vaccines?

In August, the Government announced the UK has secured access to six Covid-19 vaccine candidates in development, representing 340 million doses.

Ms Bingham said there should be about four million vaccine doses available by the end of the year.

The UK has also secured 30 million doses of the vaccine being developed by BioNtech and Pfizer.

The deals cover four different types of vaccines – adenoviral vaccines, mRNA vaccines, inactivated whole virus vaccines and protein adjuvant vaccines.

Adenoviral vaccines are weakened versions of adenoviruses, while mRNA candidates are made up of small or inactivated doses of the whole disease-causing organism.

Inactivated whole virus vaccines, on the other hand, contain whole bacteria or viruses which have been killed, while protein adjuvant jabs are those where an adjuvant is added to enhance the immune response.

Should any of these candidates be approved, the most vulnerable, the elderly, people living in care homes, and health and social care staff will be front of the queue to receive a jab, followed by those who are high at risk.

When will a coronavirus vaccine become available?

A vaccine usually takes years, often decades, to develop but scientists working on potential coronavirus jabs are hoping to achieve the same amount of work in a few months.

Most experts are optimistic that a vaccine is likely to become available by mid-2021, which would be around 12-18 months after the new coronavirus first emerged.

NHS England chief executive Sir Simon Stevens said the 'expectation' is that any vaccination programme would begin in the new year – pending positive results from clinical trials.

Meanwhile, Ms Bingham said she has 50% confidence that by Easter or early summer next year, all vulnerable people in the country will have a vaccine.

Prof Pollard said clinical trials would need to take place in the child population before Covid-19 vaccines can be given to youngsters.

He said: 'Those trials are being planned, but at the moment we do not have any data about immune response or the safety of children, and so that is something which has to be done through the normal scientific process, and I would anticipate that that will happen towards the end of this year or during the early part of next year.'

Where will the vaccines be administered?

Sir Simon said a potential vaccination programme will see vaccines delivered at GP surgeries, pharmacies and mass testing centres – including at the Nightingale hospitals.

He said GPs will be put on standby from December should a vaccine be made available before Christmas.

Popular posts from this blog

Study Abroad USA, College of Charleston, Popular Courses, Alumni

Thinking for Study Abroad USA. School of Charleston, the wonderful grounds is situated in the actual middle of a verifiable city - Charleston. Get snatched up by the wonderful and customary engineering, beautiful pathways, or look at the advanced steel and glass building which houses the School of Business. The grounds additionally gives students simple admittance to a few major tech organizations like Amazon's CreateSpace, Google, TwitPic, and so on. The school offers students nearby as well as off-grounds convenience going from completely outfitted home lobbies to memorable homes. It is prepared to offer different types of assistance and facilities like clubs, associations, sporting exercises, support administrations, etc. To put it plainly, the school grounds is rising with energy and there will never be a dull second for students at the College of Charleston. Concentrate on Abroad USA is improving and remunerating for your future. The energetic grounds likewise houses various

Best MBA Online Colleges in the USA

“Opportunities never open, instead we create them for us”. Beginning with this amazing saying, let’s unbox today’s knowledge. Love Business and marketing? Want to make a high-paid career in business administration? Well, if yes, then mate, we have got you something amazing to do!   We all imagine an effortless future with a cozy house and a laptop. Well, well! You can make this happen. Today, with this guide, we will be exploring some of the top-notch online MBA universities and institutes in the USA. Let’s get started! Why learn Online MBA from the USA? Access to More Options This online era has given a second chance to children who want to reflect on their careers while managing their hectic schedules. In this, the internet has played a very crucial in rejuvenating schools, institutes, and colleges to give the best education to students across the globe. Graduating with Less Debt Regular classes from high reputed institutes often charge heavy tuition fees. However onl

Sickening moment maskless 'Karen' COUGHS in the face of grocery store customer, then claims she doesn't have to wear a mask because she 'isn't sick'

A woman was captured on camera following a customer through a supermarket as she coughs on her after claiming she does not need a mask because she is not sick.  Video of the incident, which has garnered hundreds of thousands of views on Twitter alone, allegedly took place in a Su per Saver in Lincoln, Nebraska according to Twitter user @davenewworld_2. In it, an unidentified woman was captured dramatically coughing as she smiles saying 'Excuse me! I'm coming through' in the direction of the customer recording her. Scroll down for video An unidentified woman was captured dramatically coughing as she smiles saying 'Excuse me! I'm coming through' in the direction of a woman recording her A woman was captured on camera following a customer as she coughs on her in a supermarket without a mask on claiming she does not need one because she is not sick @chaiteabugz #karen #covid #karens #karensgonewild #karensalert #masks we were just wearing a mask at the store. ¿ o